KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Tenet Healthcare (THC) over the last 17 years, with Q4 2025 value amounting to $1.8 billion.

  • Tenet Healthcare's Other Accumulated Expenses rose 1257.0% to $1.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.8 billion, marking a year-over-year increase of 1257.0%. This contributed to the annual value of $1.8 billion for FY2025, which is 1257.0% up from last year.
  • Per Tenet Healthcare's latest filing, its Other Accumulated Expenses stood at $1.8 billion for Q4 2025, which was up 1257.0% from $1.7 billion recorded in Q3 2025.
  • Tenet Healthcare's 5-year Other Accumulated Expenses high stood at $2.2 billion for Q2 2024, and its period low was $1.2 billion during Q1 2021.
  • In the last 5 years, Tenet Healthcare's Other Accumulated Expenses had a median value of $1.6 billion in 2022 and averaged $1.6 billion.
  • As far as peak fluctuations go, Tenet Healthcare's Other Accumulated Expenses skyrocketed by 4519.36% in 2024, and later tumbled by 2763.22% in 2025.
  • Quarter analysis of 5 years shows Tenet Healthcare's Other Accumulated Expenses stood at $1.4 billion in 2021, then increased by 16.08% to $1.6 billion in 2022, then rose by 11.07% to $1.8 billion in 2023, then decreased by 8.49% to $1.6 billion in 2024, then increased by 12.57% to $1.8 billion in 2025.
  • Its Other Accumulated Expenses stands at $1.8 billion for Q4 2025, versus $1.7 billion for Q3 2025 and $1.6 billion for Q2 2025.